UnitedHealth Group (UNH) Given New $280.00 Price Target at Barclays

Share on StockTwits

UnitedHealth Group (NYSE:UNH) had its price objective raised by Barclays from $265.00 to $280.00 in a report released on Friday morning. They currently have an overweight rating on the healthcare conglomerate’s stock.

UNH has been the subject of a number of other research reports. Zacks Investment Research cut UnitedHealth Group from a buy rating to a hold rating in a report on Tuesday, June 19th. Jefferies Financial Group upped their price target on UnitedHealth Group from $270.00 to $311.00 and gave the stock a buy rating in a report on Wednesday, October 3rd. Cantor Fitzgerald reaffirmed a buy rating and issued a $300.00 price target on shares of UnitedHealth Group in a report on Thursday, July 5th. BMO Capital Markets upped their price target on UnitedHealth Group from $285.00 to $300.00 and gave the stock a positive rating in a report on Thursday, June 21st. Finally, Royal Bank of Canada upped their price target on UnitedHealth Group from $282.00 to $284.00 and gave the stock a $255.42 rating in a report on Wednesday, July 18th. One research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of Buy and an average target price of $279.26.

Shares of UNH stock traded up $2.49 on Friday, hitting $259.61. The company had a trading volume of 3,872,525 shares, compared to its average volume of 3,079,966. The stock has a market cap of $256.06 billion, a PE ratio of 25.78, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.63. UnitedHealth Group has a twelve month low of $186.00 and a twelve month high of $272.07.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.04 by $0.10. The business had revenue of $56.09 billion during the quarter, compared to analysts’ expectations of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.46 EPS. Sell-side analysts anticipate that UnitedHealth Group will post 12.72 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th were paid a dividend of $0.90 per share. The ex-dividend date was Thursday, September 6th. This represents a $3.60 annualized dividend and a yield of 1.39%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of the business’s stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 1st. The stock was sold at an average price of $254.79, for a total value of $3,821,850.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of the business. White Lighthouse Investment Management Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $324,000. Wells Fargo & Company MN grew its position in shares of UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Wesbanco Bank Inc. grew its position in shares of UnitedHealth Group by 195.2% in the first quarter. Wesbanco Bank Inc. now owns 76,341 shares of the healthcare conglomerate’s stock valued at $16,337,000 after purchasing an additional 50,480 shares in the last quarter. Granite Investment Advisors LLC grew its position in shares of UnitedHealth Group by 1.4% in the second quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock valued at $8,397,000 after purchasing an additional 476 shares in the last quarter. Finally, M Holdings Securities Inc. grew its position in shares of UnitedHealth Group by 12.1% in the second quarter. M Holdings Securities Inc. now owns 5,128 shares of the healthcare conglomerate’s stock valued at $1,258,000 after purchasing an additional 553 shares in the last quarter. Institutional investors own 85.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What kind of dividend yield to CEF’s pay?

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply